Back to Market Feed

NEUPOGEN 300 MCG/ML VIAL

$305.8920per ML

Strength

300 ug/mL

Manufacturer

NDC

55513053010

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

1/21/2026

Active Ingredients

Approval Type

Biologic (BLA)

FDA Application

On Market Since

5/19/1997

Pharmacological Classes

Granulocyte Colony-Stimulating Factor

Increased Myeloid Cell Production

Leukocyte Growth Factor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+0.1%

1Y

-0.2%

3Y

+5.0%

5Y

+5.0%

All

+7.2%

Generic Alternatives

1 alternative • Same active ingredient

NEUPOGEN 300 MCG/0.5 ML SYR

55513092410•Amgen Inc.

Related Drugs

Same classification

NEULASTA 6 MG/0.6 ML SYRINGE

55513019001•Amgen Inc.